November 22, 2021 BARRON’S 45
Research Reports
HowAnalystsSizeUpCompanies
Thesereports,excerptedandeditedbyBarron’s,wereissuedrecentlybyinvestmentand
research firms. The reports are a sampling of analysts’ thinking; they should not be
consideredtheviewsorrecommendationsofBarron’s.Someofthereports’issuershave
provided, or hope to provide, investment-banking or other services to the companies
being analyzed.
To be considered for this section, material
should be sent [email protected].
Lowe’s•LOW-Nasdaq
Neutral•Price $245.73 on Nov. 17
by Wedbush
Lowe’s reported third-quarter results that
met buy-side expectations on sales comps,
but beat on margins. Home improvement
demand remains solid. LikeHome Depot
(ticker: HD), Lowe’s did not experience any
material negative demand from higher
prices. Despite more difficult comparisons in
December and January, Lowe’s implied
fourth-quarter flattish comp guidance is
very conservative. All in, it reported operat-
ing margins of 12.2% (+240 basis points
[each equal to 1/100th of a percentage
point], year over year) versus the consensus
10.8% estimate, and earnings per share of
$2.73 versus the consensus $2.35. The com-
pany plans to address its 2022 outlook at a
virtual meeting on Dec. 15. While Lowe’s is
executing well and has material medium-
term margin expansion potential, we con-
tinue to favor HD, given its higher exposure
[to construction and home-improvement
pros.] We are raising our estimates, increas-
ing our target price to $260 from $210, but
reiterating our Neutral rating on Lowe’s.
Cisco Systems•CSCO-Nasdaq
Outperform•Price $56.86 on Nov. 17
by Evercore ISI
Cisco reported October-quarter results of
$12.9 billion in sales and 82 cents in EPS,
versus the Street consensus of $13 billion/80
cents. Cisco saw strong 8% top-line growth,
driven by strength across several key seg-
ments (Internet of future +46%, Secure Ag-
ile networks +10%). The challenge with the
print was that its January-quarter guidance
came in below expectations. Cisco is calling
for 4.5% to 6.5% sales growth, versus the
Street’s 7.3%, in light of supply-chain chal-
lenges. Positively, Cisco maintained its fiscal-
year 2021 guidance of 5% to 7% top-line
growth and noted that it is seeing signs of
supply-chain normalization. In addition,
robust order growth, which accelerated to
+33% in the quarter (versus 31% in July),
should give investors confidence in the multi-
year growth profile as supply-chain issues
fade and information-technology deployments
accelerate, driven by the shift in digital
transformation. We are sticking with our $67
price target.
Sportradar Group•SRAD-Nasdaq
Buy•Price $21.83 on Nov. 17
by Needham
We see Sportradar’s shares as a compelling,
way of benefiting from the growth of sports
betting globally and the increasing impor-
tance of in-game betting. Sportradar [which
provides event data to sportsbooks] has
signed an exclusive contract with the NBA,
following the loss of its NFL contract to
GeniusSports(GENI, Buy, $29 PT). We are
encouraged that Sportradar is adding reve-
nue sources like distribution streaming rights
and directing advertising spending on behalf
of sportsbooks. We see the risk-reward ratio
skewing toward our bull case, given the im-
portance of high-quality data as in-game bet-
ting becomes increasingly important. We are
increasing our price target to $30 [from $28].
Activision Blizzard•ATVI-Nasdaq
Outperform•Price $66.14 on Nov. 16
by BMO Capital Markets
The Wall Street Journal published an article
[a few days ago] alleging that CEO Bobby
Kotick knew about sexual misconduct at the
company [but mishandled the situation].
While Activision Blizzard has stated that the
article was misleading, pressure continues to
mount, and we expect it’s becoming increas-
ingly more likely that Kotick steps down. We
maintain our Outperform rating, as we see
significant value in Activision’s intellectual
property and game brands. We anticipate the
stock will see a relief bounce if Kotick re-
signs, and note the depressed share price
could make it an attractive takeover target
for a larger tech company. Price target: $90.
PNC Financial Services•PNC-NYSE
Perform•Price $199.13 on Nov. 18
by Oppenheimer
PNC reported third-quarter EPS of $3.30,
versus the consensus $3.35; however, these
figures contain noise from reserve releases
and merger-related items. On a core basis,
we’d place EPS at around $3.55, versus our
estimate of $3.09, mainly on lower charge-
offs and strong private-equity gains. On bal-
ance, the results leave our outlook for 2022
and beyond basically unchanged. We gener-
ally like PNC. It has good businesses, a
solid track record, and well-regarded man-
agement. The company’s longer-term
growth prospects are very favorable, but its
valuation keeps us on the sidelines.
Fresenius Medical Care•FMS-NYSE
Sector Perform•Price $32.96 on Nov. 15
by RBC Research
Fresenius [which provides kidney dialysis
and related services and products] posted
third-quarter results in line with expecta-
tions, despite reacceleration of excess mortal-
ity from Covid-19, due to the Delta variant.
Despite this, the company achieved 1.2%
organic top-line growth, driven by a reim-
bursement increase in the U.S., continued
payor-mix improvement from strong Medi-
care Advantage growth, and solid underlying
demand and return of elective medical proce-
dures in the Asia-Pacific region. However, we
are lowering our price target to $35 from
$42, primarily on sector rerating.
INSIDER TRANSACTIONS RATIO
0
19
38
57
76
95
114
133
152
N D J F M A M J J A S O N
Ratio of Insiders Sales to Buys. Readings under 12:1 are Bullish. Those over 20:1 are Bearish.
The total top20 sales and buys are 788, 955 ,816 and 60, 472 ,537 respectively; Source: Thomson Reuters
Bearish
Bullish
Ratio = 13
INSIDER TRANSACTIONS: Recent Filings
Purchases
$ Val
Company/Symbol Insiders Shares (000's)
Io BiotechIOBT 3 1,050,000 14,700
Uber TechnologiesUBER 1 200,000 8,985
Perimeter SolutionsPRM 4 546,914 5,469
Continental ResourcesCLR 1 108,500 5,174
PlaytikaPLTK 1 150,000 3,243
Illinois Tool WorksITW 1 10,000 2,353
Moneygram InternationalMGI 10 403,292 2,342
Sarepta TherapeuticsSRPT 1 25,026 2,001
PaypalPYPL 1 9,780 1,999
SylvamoSLVM 4 60,340 1,879
Thryv HTHRY 1 45,000 1,598
American Assets TrustAAT 1 35,535 1,382
EhealthEHTH 4 44,056 1,305
Jackson FinancialJXN 1 38,925 1,283
FiskerFSR 3 57,434 1,256
Krispy KremeDNUT 2 90,000 1,248
Wheels Up ExperienceUP 1 200,000 1,156
Boston ScientificBSX 1 25,000 1,049
Bluegreen VacationsBVH 2 33,403 1,026
Whiting PetroleumWLL 1 15,150 1,025
Sales
$ Val
Company/Symbol Insiders Shares (000's)
RobloxRBLX 5 902,095 94,264
DatadogDDOG 4 348,879 66,720
WorkivaWK 1 330,000 49,830
Vita CocoCOCO 1 3,240,000 48,600
ConfluentCFLT 3 573,712 47,260
ApplovinAPP 2 395,833 42,250
Coinbase GlobalCOIN 2 119,490 41,406
Advanced Micro DevicesAMD 5 257,416 38,514
Knowbe4KNBE 1 1,538,246 38,025
UpstartUPST 4 151,500 37,741
Site CentersSITC 1 2,100,000 34,723
Avis BudgetCAR 4 123,054 33,221
C3AiAI 3 646,219 31,227
Amc EntertainmentAMC 5 763,331 30,755
DropboxDBX 3 1,051,721 28,046
Installed Building ProductsIBP 2 202,000 26,637
RokuROKU 4 97,475 26,586
RevolveRVLV 3 308,723 25,229
ZiprecruiterZIP 4 802,941 24,411
Big 5 Sporting GoodsBGFV 6 574,098 23,511
Aninsiderisanyofficer,directororownerof10%ormoreofaclassofacompany'ssecurities.Inmostcases,aninsidermustreportanytradetothe
SECwithintwobusinessdays.ThetableshighlightcompaniesthatfiledwiththeSECthroughlastWednesday.Thetablesdonotincludepension-
planoremployeestock-optionactivity,tradesbybeneficialownersof10%ormore,tradesunder$2pershareortradesunder100shares.The
"Purchases"columnincludesonlyopen-marketandprivatepurchases;the"Sales"columnincludesonlyopen-marketandprivatesales,and
excludestradesprecededbyoptionexerciseinthe12monthspriortothereportedevent. Source:ThomsonReuters